This inventor holds 1 USPTO granted patent. Top assignee: University Technologies International, Inc.. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Caren C Helbing: Innovator in Apoptosis Modulation
Introduction
Caren C Helbing is a distinguished inventor based in Calgary, Canada. She has made significant contributions to the field of cellular biology, particularly in the area of apoptosis modulation. Her innovative work has implications for understanding cell death and its regulation in eukaryotic cells.
Latest Patents
Caren C Helbing holds a patent for "Methods of modulating apoptosis." This invention provides novel methods for modulating apoptosis in eukaryotic cells using peptides and proteins derived from p33.sup.ING1 or oligonucleotides derived from the ING1 gene. The invention also includes methods for determining the apoptotic characteristics of a eukaryotic cell. She has 1 patent to her name.
Career Highlights
Caren is associated with University Technologies International, Inc., where she continues to advance her research and innovations. Her work has garnered attention for its potential applications in therapeutic settings.
Collaborations
Caren has collaborated with notable colleagues, including Karl T Riabowol and Randall N Johnston. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Caren C Helbing is a prominent figure in the field of apoptosis research, with a focus on innovative methods that could lead to significant advancements in cellular biology. Her contributions continue to inspire future research and development in this critical area.